Lutathera Shows Promise as Part of Initial Therapy for Some Neuroendocrine Tumors - Cancer Currents Blog

National Cancer Institute sent this bulletin at 03/01/2024 10:35 AM EST

Having trouble viewing this email? View it as a Web page.

Lutathera Shows Promise as Part of Initial Therapy for Some Neuroendocrine Tumors
03/01/2024
	Adding Lu 177-dotate to the initial treatment of certain advanced neuroendocrine tumors nearly tripling the length of time people survive without their tumors getting worse, according to new clinical trial results.

You are subscribed to the latest posts from Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Update your subscriptions.